-

Milliman analysis: Corporate pension funded status unchanged in July after market gains offset drop in discount rate

Milliman PFI funded ratio remains at 103.5%, ending six straight months of improvements

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the results of its latest Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.

During July, the Milliman 100 PFI funded status held steady at its $44 billion surplus level, while the funded ratio remained at 103.5%, the same level noted as of June 30. Discount rates fell by 16 basis points in July, to 5.30%, which caused pension liabilities to rise from $1.262 trillion to $1.284 trillion during the period. However, monthly investment returns of 2.17% offset this change, lifting the PFI plan assets from $1.306 trillion as of June 30 to $1.328 trillion as of July 31.

“July’s offsetting asset and liability movements left the funded ratio unchanged and ended the six-month streak of improvements,” said Zorast Wadia, author of the PFI. “With markets coming off all-time highs and discount rates possibly falling further, we may see funded status volatility in the second half of 2024, making asset-liability matching a prudent strategy for plan sponsors.”

Looking ahead, under an optimistic forecast with rising interest rates (reaching 5.55% by the end of 2024 and 6.15% by the end of 2025) and annual asset returns of 10.4%, the funded ratio would climb to 108% by the end of 2024 and 121% by the end of 2025. Under a pessimistic forecast with similar interest rate and asset movements (5.05% discount rate at the end of 2024 and 4.45% by the end of 2025 and 2.4% annual asset returns), the ratio is projected to decline to 100% by the end of 2024 and 90% by the end of 2025.

To view the complete Pension Funding Index, go to www.milliman.com/pfi. To see Milliman’s full range of annual Pension Funding Studies, go to https://www.milliman.com/en/retirement-and-benefits/pension-funding-studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman is among the world's largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. For further information, visit milliman.com.

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

Milliman, Inc.


Release Summary
Milliman has just released the latest results of our corporate Pension Funding Index.
Release Versions

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom